Androgen deprivation for prostatic carcinoma: a rationale for choosing components

Area of Science:

• Oncology
• Endocrinology

Background:

• Prostate carcinoma proliferation is androgen-dependent.
• Androgen deprivation therapy is the standard for advanced prostate cancer.
• Treatment options have evolved from castration to complex modalities.

Purpose of the Study:

• To review factors influencing treatment strategy selection for advanced prostate cancer.
• To emphasize patient tolerance and compliance in treatment choice.

Main Methods:

• Literature review of androgen deprivation therapies for prostate cancer.
• Analysis of treatment modalities including LHRH analogues and antiandrogens.

Main Results:

• Treatment selection is complex due to various available modalities.
• Patient-centered factors like tolerance and compliance are crucial.

Conclusions:

• Optimal treatment choice balances efficacy with patient tolerability.
• Long-acting, non-toxic treatments with simple regimens improve compliance.